Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Drug Safety
|
April 12, 2002
Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence
William Jeffcoate
Clinics in Podiatric Medicine and Surgery
|
January 1, 2008
The causes of the Charcot syndrome
William Jeffcoate
Advances in Skin & Wound Care
|
August 21, 2013
The charcot foot: neuropathic osteoarthropathy
Fran Game, William Jeffcoate
Diabetes Care
|
July 7, 2022
The Charcot Foot Reflects a Response to Injury That Is Critically Distorted by Preexisting Nerve Damage: An Imperfect Storm
William Jeffcoate, Fran Game
The Medical Clinics of North America
|
September 3, 2013
Epidemiology of foot ulceration and amputation: can global variation be explained?
David J Margolis, William Jeffcoate
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 16, 2023
The value of loss of protective pain sensation in predicting a first ulceration of the foot in people with diabetes
Anna Trocha, Veronika Gontscharuk, Andrea Icks, et al.
Lancet (London, England)
|
August 11, 2004
Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation
Mervyn Singer, Vincenzo De Santis, Domenico Vitale, et al.
Diabetes Care
|
February 27, 2010
Mortality associated with acute Charcot foot and neuropathic foot ulceration
Juliette van Baal, Richard Hubbard, Fran Game, et al.
Trials
|
November 28, 2014
Evaluation of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: study protocol for a randomised controlled trial
William Jeffcoate, Frances Game, Patricia Price, et al.
Trials
|
October 12, 2017
The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trial
Frances Game, William Jeffcoate, Lise Tarnow, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Drug Safety
|
April 12, 2002
Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence
William Jeffcoate
Clinics in Podiatric Medicine and Surgery
|
January 1, 2008
The causes of the Charcot syndrome
William Jeffcoate
Advances in Skin & Wound Care
|
August 21, 2013
The charcot foot: neuropathic osteoarthropathy
Fran Game, William Jeffcoate
Diabetes Care
|
July 7, 2022
The Charcot Foot Reflects a Response to Injury That Is Critically Distorted by Preexisting Nerve Damage: An Imperfect Storm
William Jeffcoate, Fran Game
The Medical Clinics of North America
|
September 3, 2013
Epidemiology of foot ulceration and amputation: can global variation be explained?
David J Margolis, William Jeffcoate
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 16, 2023
The value of loss of protective pain sensation in predicting a first ulceration of the foot in people with diabetes
Anna Trocha, Veronika Gontscharuk, Andrea Icks, et al.
Lancet (London, England)
|
August 11, 2004
Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation
Mervyn Singer, Vincenzo De Santis, Domenico Vitale, et al.
Diabetes Care
|
February 27, 2010
Mortality associated with acute Charcot foot and neuropathic foot ulceration
Juliette van Baal, Richard Hubbard, Fran Game, et al.
Trials
|
November 28, 2014
Evaluation of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: study protocol for a randomised controlled trial
William Jeffcoate, Frances Game, Patricia Price, et al.
Trials
|
October 12, 2017
The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trial
Frances Game, William Jeffcoate, Lise Tarnow, et al.
Page
of 3